ARCHIVES

Bill Would Harm Pancreatic Cancer Research – Scientists Warn Of Unintended Consequences

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

In Brief: NCI to Extend Frederick contract To SAIC; Klausner, Gallin, Gail Elected to IOM

October 24, 1996

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994

Book For Survivors, Other New Publications

August 23, 1991

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

March 31, 2000